XEW

N-(4-chlorophenyl)-N'-(propan-2-yl)triimidodicarbonic diamide

Created: 2022-11-14
Last modified:  2023-02-01

Find related ligands:

Chemical Details

Formal Charge0
Atom Count33
Chiral Atom Count0
Bond Count33
Aromatic Bond Count6
2D diagram of XEW

Chemical Component Summary

NameN-(4-chlorophenyl)-N'-(propan-2-yl)triimidodicarbonic diamide
Systematic Name (OpenEye OEToolkits)1-(4-chlorophenyl)-3-(~{N}-propan-2-ylcarbamimidoyl)guanidine
FormulaC11 H16 Cl N5
Molecular Weight253.731
TypeNON-POLYMER

Chemical Descriptors

TypeProgram Version Descriptor
SMILESACDLabs12.01Clc1ccc(NC(=N)NC(=N)NC(C)C)cc1
SMILESCACTVS3.385CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1
SMILESOpenEye OEToolkits2.0.7CC(C)NC(=N)NC(=N)Nc1ccc(cc1)Cl
Canonical SMILESCACTVS3.385 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1
Canonical SMILESOpenEye OEToolkits2.0.7 [H]/N=C(\Nc1ccc(cc1)Cl)/N/C(=N\[H])/NC(C)C
InChIInChI1.06 InChI=1S/C11H16ClN5/c1-7(2)15-10(13)17-11(14)16-9-5-3-8(12)4-6-9/h3-7H,1-2H3,(H5,13,14,15,16,17)
InChIKeyInChI1.06 SSOLNOMRVKKSON-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank IDDB01131 
NameProguanil
Groups approved
DescriptionProguanil is a prophylactic antimalarial drug, which works by stopping the malaria parasite, _Plasmodium falciparum_ and _Plasmodium vivax_, from reproducing once it is in the red blood cells. It does this by inhibiting the enzyme, dihydrofolate reductase, which is involved in the reproduction of the parasite.
Synonyms
  • Proguanilum
  • Chlorguanide
  • Proguanil
  • Proguanilo
  • Chloroguanide
Brand Names
  • Mylan-atovaquone/proguanil
  • Malarone
  • Atovaquone and Proguanil Hydrochloride
  • Teva-atovaquone Proguanil
  • Paludrine Tab 0.1gm
IndicationFor the causal prevention and suppression of malaria caused by susceptible strains of <i>P. falciparum</i> and other species of Plasmodium found in some geographical areas of the world.
Categories
  • Amidines
  • Anti-Infective Agents
  • Antimalarials
  • Antimetabolites
  • Antiparasitic Agents
ATC-Code
  • P01BB01
  • P01BB51
  • P01BB52
CAS number500-92-5

Drug Targets

NameTarget SequencePharmacological ActionActions
Dihydrofolate reductaseMVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNL...unknowninhibitor
Bifunctional dihydrofolate reductase-thymidylate synthaseMMEQVCDVFDIYAICACCKVESKNEGKKNEVFNNYTFRGLGNKGVLPWKC...unknowninhibitor
Cytochrome P450 2C9MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDI...unknownsubstrate
Cytochrome P450 2C19MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDV...unknownsubstrate
Cytochrome P450 2D6MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVD...unknowninhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 5353897, 4923, 6328384, 5361395, 6178111
ChEMBL CHEMBL1377
ChEBI CHEBI:8455
CCDC/CSD CPPBGC